NAsdaq

Спайдер незначительно повышается перед открытием торгов на NYSE.  

• Европейские индексы на положительной  территории.  

SPY (внутридневной график)  боковое движение   премаркете. Поддержка 167.00, сопротивление 168.00  
Премаркет NYSE/NASDAQ:
Gapping up:

• In reaction to strong earnings/guidance: CMTL +11.2%.
• Select financial related names showing strength: NBG +4.8%, IRE +3.3%, SAN +1.6%, DB +0.7%.
• Other news: DSCO +52.3% (announced FDA has agreed to the Co's updated product specifications for SURFAXIN), FST +10.2% (announces sale of Texas Panhandle Area assets for proceeds of $1.0 bln), STXS +5.8% (may be related to medical device news yesterday, still checking), NOAH +6.3% (light volume, Noah Holdings States that its policy is not to comment on unusual market activity or rumors),  FI +4.5% (positive MadMoney mention), TSLA +2.1% (Tesla Motors and Samsung (SSNLF) are in talks over battery supplies deal, according to reports), TTM +2% (Tata Motors trading 2% higher premarket following strength in overseas trading), FFIV +1.6% (positive MadMoney mention), RAD +1.4% (continued strength following comps), STJ +1.1% (continued strength on reports that some Dems support repeal of medical device tax), JCP +1.1% (still checking), FB +0.9% (following Twitter news, Facebook's Instagram set to introduce ads over the next few months, according to the company's blog), AAPL +0.5% (Apple buys Cue for over $40 mln to compete with Google Now, according to reports).

( Читать дальше )

Добавлен тариф «Фиксированный» для трейдеров, которые хотят иметь минимальную комиссию 0.01$ за 100 акций, торгуя на платформе Sterling Trader (130$/мес.), с возможностью overnight позиций. За дополнительной информацией обращайтесь в skype: mosaic.fma

Спайдер повышается перед открытием торгов на NYSE.  

• Европейские индексы на отрицательной территории.  

SPY (внутридневной график)  боковое движение   премаркете. Поддержка 167.75, сопротивление 169.00  
Премаркет NYSE/NASDAQ:
Gapping up:

• In reaction to strong earnings/guidance: CAMP +9.7%, EVAC +3.3%, STZ +2.1%, PVH +1.2% (sells GH Bass business to GIII; updates Q3 EPS guidance above consensus; reaffirms FY13 EPS ).
• M&A news: MNTG +8.5% ( Jacobs Entertainment, 18.14% active holder, submits a formal proposal for an Agreement and Plan of Merger). 
• Select drug/pharma related names showing strength: GSK +1.4%, TEVA +0.8%, VRX +0.5% ( announces approval Of Jublia for the treatment of onychomycosis in Canada; Bausch + Lomb Receives FDA Clearance For Novel Monthly Disposable Contact Lens), SNY +0.2% (Sanofi-Aventis unit Genzyme reports Aubagio significantly reduced risk of new clinical relapse or MRI lesion in multiple sclerosis study).
• Other news: OCZ +5% (announces settlement of consolidated shareholder class action litigation; settlement of $7.5 mln will be funded by the co's D&O liability insurance), SQNM +4.9% (files premarket 510(k) notification with FDA for IMPACT Dx system), GALE +4.8% (Galena Biopharma launches Abstral (fentanyl) Sublingual Tablets for the treatment of breakthrough cancer pain), HIMX +3.6% (still checking), AAT +3.2% (AAT to replace FIRE in the S&P SmallCap 600), OMER +3.2% (Omeros unlocks six additional Class A orphan GPCRs and identifies small molecules targeting two commercially validated Class B GPCRs; also Settles Insurance Litigation), CHU +2.8% (China Unicom gapping up following strength in overseas trading), TTM +2.2% (following strength in overseas trading), GST +1.8% (announced earlier funding of sale of East Texas property), VIPS +1.6% (following yesterday's 8% move higher), NBG +1.4% (Natl Bank of Greece and other Greek lenders have put some loans into 'bad banks', according to reports), HLF +1.2% (Bill Ackman's Pershing Square provides portfolio update in Q3 letter to investors), BP +1.2% (BP confirms ruling by U.S. Court of Appeals for the Fifth Circuit.), CSIQ +1.1% ( announces the sale of two utility scale solar power plants to a fund managed by BlackRock), VOD +0.8% (announced that its Group CFO, Andy Halford, has informed the Board that he intends to leave the Group at the end of March 2014 ), LCC +0.8% (US Airways Sept RPMs +3.5% YoY; ASM +3.8%), MODN +0.7% (light volume, disclosed earlier a reduction in the size of its workforce, primarily in professional services ), .

( Читать дальше )

Акции Google (NASDAQ: GOOG) на подъеме, с момента возвращения Ларри Пейджа на пост генерального директора. Цена за акцию выросла более чем на 40%, примерно как акции Apple  за тот же период и сильнее того что мы видели от Microsoft и рынка в целом. Для инвесторов это не должно быть неожиданностью.
Ларри Пейдж, как и его бизнес-партнер Сергей Брин,  преданные идее основатели компании. История показывает, что основатели компаний, имеющие большие доли в бизнесе, делают значительно больше для компании и для инвесторов в целом. Прекрасный тому пример Стив Джобс и созданная им корпорация Apple, Марк Цукерберг, являющийся основателем и генеральным  директором Facebook, которая кстати, уже превысила цену IPO.
Эти люди не боятся внедрять рисковые инновационные идеи, делают все возможное для роста бизнеса, потому что им есть что терять. В случае Пейджа, Google показала возражденный интерес к безумным инновациям вроде Google Glass и проекта по увеличению длительности  жизни человека Calico, множество интегрированных через «облако» приложений и многое другое.


( Читать дальше )

Обзор от компании Manhattan Investment Group International по наиболее интересным акциям на 13:00 дня (New York time) среды 2.10.2013

Спайдер понижается перед открытием торгов на NYSE.  

• Европейские индексы на отрицательной территории.  

SPY (внутридневной график)  снижение на   премаркете. Поддержка 168.00, сопротивление 168.75   
Премаркет NYSE/NASDAQ:
Gapping up:

• In reaction to strong earnings/guidance: GPN +6.9%, ADSK +1.3%.
• M&A news: OIBR +14.8%  and  PT +14.3% (Portugal Telecom and Oi SA announce MOU for merger of activities).
• Select metals/mining stocks trading higher: MT +0.9%, GDX +0.8%, CDE +0.7%, NEM +0.6%, GG +0.6%, SLV +0.4%, GLD +0.2%.
• Other news: DCTH +49.3% (FDA grants orphan drug designation to Delcath Systems for use of melphalan hydrochloride in HCC), ALVR +7.7% (continued strength), MCP +5.4% (announced mechanical completion and the start of commissioning of both the Chloralkali plant and the final unit of multi-stage cracking at mountain pass ), ALLT +5.3% (Allot Comms receives multimillion dollar order from major U.S. based cloud provider), PEIX +3.9% (to use sugar to further diversify its feedstock ), ALU +3.5% (still checking), TWGP +2.7% (announces it has entered into agreements with three reinsurers to enhance the company's financial flexibility ), LEE +2.3% (Lee Enterprises debt reduction two years ahead of plan), PSTI +1.7% (receives Israeli Ministry of Health approval to expand its Phase II clinical trial in intermittent claudication to Israel), NOK +1.2% (still checking), ETP +1.1% (announces project development agreement).

( Читать дальше )

Обзор от компании Manhattan Investment Group International по наиболее интересным акциям на 11:30 утра (New York time) вторника 1.10.2013

Спайдер повышается перед открытием торгов на NYSE.  

• Европейские индексы на положительной территории.  

SPY (внутридневной график)  рост на   премаркете. Поддержка 167.75, сопротивление 169.00  
Премаркет NYSE/NASDAQ:
Gapping up:

• In reaction to strong earnings/guidance: MRK +1.7% (announces global initiative to sharpen commercial and R&D Focus; Co reaffirms 2013 full-year non-GAAP EPS target of $3.45-3.55).
• M&A news: EDG +56.6% (discloses Agreement and Plan of Merger,  each issued and outstanding share of Class A common stock will be converted into the right to receive $12.00 in cash).
• Select financial related names showing strength: CS +2.5%, ING +2.2%, BCS +2.1%, IBN +2%, PUK +1.8%, HBC +1.1%.
• Select solar stocks trading higher: SFUN +3.2%, SOL +2.6%, STP +2.4%, SPWR +2.4%, FSLR +2.2%.
• Other news: LXRX +24.5% (achieves 'positive' Results in Type 2 Diabetes Patients with Renal Impairment; LX4211 provided clinically meaningful and statistically significant reductions), ALVR +13.6% (thinly traded, continued strength), MYGN +8.5% (following late sell-off that was being attributed to analyst comments on pricing for BRCA test; disclosed and confirmed that the Centers for Medicare & Medicaid Services released finalized pricing for the new molecular pathology codes for 2014, upgraded to Buy at Ladenburg Thalmann), HCI +3.8% (to replace MFB in the S&P SmallCap 600), PSTI +3.6% (PLX Cells demonstrate efficacy in preclinical study for graft versus host disease), ALU +3.4% (Alcatel-Lucent outlines the Shift Plan strategy to accelerate telecommunications to the cloud), RAD +2.3% (following WAG results), SI +2.1% and TEF +1.4% (still checking), JCP +1% ( discloses its proceeds before expenses from offering of 84 mln shares of common stock was $786.24 mln ), AMZN +0.6% (Amazon Creating 70,000 Full-Time Seasonal Jobs in the U.S. to Fulfill Holiday Orders with Thousands Expected to Become Permanent Employees), FB +0.1% (plans to expand Graph Search, according to reports), .

( Читать дальше )

Обзор от компании Manhattan Investment Group International по наиболее интересным акциям на 12:30 дня (New York time) понедельника 30.09.2013

Аналитика NYSE на 30 сентября
 
Спайдер снижается перед открытием торгов на NYSE.  

• Европейские индексы на отрицательной территории.

 
SPY (внутридневной график)  снижение на   премаркете. Поддержка 167.50, сопротивление 168.00
 
 
Премаркет NYSE/NASDAQ:
Gapping up:

• In reaction to strong earnings/guidance: CRRS +7.8%.
• M&A news: ACTV +27.4% (Active Network to be acquired by Vista Equity Partners; stockholders to receive $14.50 per share), CHRM (Charm Communications announces receipt of 'going private' proposal priced at $4.70 per ADS).
• Other news: DCTH +30% (received Orphan Drug Designation for Treatment of patients with hepatocellular carcinoma ), ORB +8% (Orbital Sciences' unmanned cargo ship has reached the Intl space station, according to reports), QCOR +4.6% (still checking), NSPH +4.3% ( Study Demonstrates Significant Clinical and Economic Impact of Nanosphere's Verigene Blood Culture Test; Average per Patient Hospital Cost Savings of $60,000 and 22 Day Reduction in Length of Stay Observed), ZAZA +4% ( Announces Second Transaction with JV Partner to Acquire Additional Production and Further Develop Its Eaglebine/Eagle Ford East Assets), RMTI +3.1% (continued strength), CYTR +1.8% (reports new Aldoxorubicin data that demonstrates significant advantages over doxorubicin; provides additional updates on other Phase 2 studies ), HALO +1.8% (presents PEGPH20 Phase 1b clinical trial data that suggest a potential clinical benefit of using PEGPH20 with gemcitabine in patients with high levels of tumor associated hyaluronan), HNR +1.4% (announces exclusive negotiations to sell interest in Gabon for $137 mln in cash), AZN +0.6% (NKTR reported that partner AZN announced European Medicines Agency acceptance of Marketing Authorisation Application for Naloxegol), PMT +0.6% ( Hayman Capital Management discloses 5.1% passive stake in 13G filing out Friday after the close).

( Читать дальше )